Previous studies have shown that decorin and biglycan account for over 70% of the proteoglycans (PGs) synthesized by human peritoneal mesothelial cells (HPMCs). Since these PGs are involved in the control of cell growth, cell differentiation, and matrix assembly, we investigated their turnover in cultured HPMCs.
Methods
Confluent HPMCs were metabolically labeled with [35S]-sulfate and the labeled products isolated from the cell medium and the cell layer characterized by sensitivity to bacterial eliminases. Experiments were undertaken with exogenous labeled decorin, and its metabolic state was studied.
Results
In a 24-hour labeling period, 75% of the newly synthesized chondroitin sulfate/dermatan sulfate (CS/DS) PGs appeared in the culture medium, the majority of which (90%) was decorin. In the cell layer, protein-free glycosaminoglycan (GAG) chains accounted for 21% of the total CS/DS at 24 hours and exhibited constant specific activity at 12 – 16 hours. The latter material was turned over with a half-life of approximately 2.5 hours. Exogenous decorin underwent receptor-mediated endocytosis and subsequent intracellular degradation. Uptake but not degradation could be inhibited by heparin.
Conclusions
HPMCs are distinguished by a rapid turnover of decorin. A characteristic metabolic feature is the existence of a large intracellular pool of protein-free DS-GAGs. Understanding the control of decorin turnover in HPMCs might lead to delineation of its potential role in both the physiology and pathophysiology of the membrane in PD patients.
KresseH., SchonherrE.Proteoglycans of the extracellular matrix and growth control.J Cell Physiol2001; 189: 266–74.
3.
SantraM., MannD.M., MercerE.W., SkorskiT., CalabrettaB., IozzoR.V.Ectopic expression of decorin protein core causes a generalized growth suppression in neoplastic cells of various histogenetic origin and requires endogenous p21, an inhibitor of cyclin-dependent kinases.J Clin Invest1997; 100: 149–57.
SchonherrE., LevkauB., SchaeferL., KresseH., WalshK.Decorin-mediated signal transduction in endothelial cells. Involvement of Akt/protein kinase B in upregulation of p21 (WAF1/CIP1) but not p27 (KIP1).J Biol Chem2001; 276: 40687–92.
6.
SchonherrE., O'ConnellB.C., SchittnyJ., RobenekH., FastermannD., FisherL.W.Paracrine or virusmediated induction of decorin expression by endothelial cells contributes to tube formation and prevention of apoptosis in collagen lattices.Eur J Cell Biol1999; 78: 44–55.
7.
DobbieJ.W., ZakiM.A.The ultrastructure of the parietal peritoneum in normal and uraemic man in patients on CAPD. In: MaherJ.F., WinchesterJ.F., eds. Frontiers in Peritoneal Dialysis.New York: Field Rich and Associates; 1986: 3–10.
8.
HillsB.A.Role of surfactant in peritoneal dialysis.Perit Dial Int2000; 20: 503–15.
StapransI., PielC.F., FeltsJ.M.Analysis of selected plasma constituents in continuous ambulatory peritoneal dialysis effluent.Am J Kidney Dis1986; 7: 490–4.
11.
YungS., ThomasG.J., StylianouE., WilliamsJ.D., ColesG.A., DaviesM.Source of peritoneal proteoglycans. Human peritoneal mesothelial cells synthesize and secrete mainly small dermatan sulfate proteoglycans.Am J Pathol1995; 146: 520–9.
12.
BreuerB., SchmidtG., KresseH.Non-uniform influence of transforming growth factor-beta on the biosynthesis of different forms of small chondroitin sulphate/dermatan sulphate proteoglycan.Biochem J1990; 269: 551–4.
13.
BorderW.A., OkudaS., LanguinoL.R., RuoslahtiE.Transforming growth factor-beta regulates production of proteoglycans by mesangial cells.Kidney Int1990; 37: 689–95.
14.
Westergren-ThorssonG., AntonssonP., MalmstromA., HeinegardD., OldbergA.The synthesis of a family of structurally related proteoglycans in fibroblasts is differently regulated by TGF-beta.Matrix1991; 11: 177–83.
15.
JarvelainenH.T., KinsellaM.G., WightT.N., SandellL.J.Differential expression of small chondroitin/dermatan sulfate proteoglycans, PG-I/biglycan and PG-II/decorin, by vascular smooth muscle and endothelial cells in culture.J Biol Chem1991; 266: 23274–81.
16.
EdwardsI.J., XuH., WrightM.J., WagnerW.D.Interleukin-1 upregulates decorin production by arterial smooth muscle cells.Arterioscler Thromb1994; 14: 1032–9.
17.
KurodaK., ShinkaiH.Downregulation of decorin expression in dermal fibroblasts by interleukin-4.Arch Dermatol Res1997; 289: 476–80.
18.
HausserH., HoppeW., RauchU., KresseH.Endocytosis of a small dermatan sulphate proteoglycan. Identification of binding proteins.Biochem J1989; 263: 137–42.
19.
WinterA.D., CampbellM.A., RobinsonH.C., HandleyC.J.Catabolism of newly synthesized decorin by explant cultures of bovine ligament.Matrix Biol2000; 19: 129–38.
20.
StylianouE., JennerL.A., DaviesM., ColesG.A., WilliamsJ.D.Isolation, culture and characterization of human peritoneal mesothelial cells.Kidney Int1990; 37: 1563–70.
ThomasG.J., MasonR.M., DaviesM.Characterization of proteoglycans synthesized by human adult glomerular mesangial cells in culture.Biochem J1991; 277: 81–8.
23.
LyonM., GallagherJ.T.Purification and partial characterization of the major cell-associated heparan sulphate proteoglycan of rat liver.Biochem J1991; 273: 415–22.
24.
BeavanL.A., DaviesM., CouchmanJ.R., WilliamsM.A., MasonR.M.In vivo turnover of the basement membrane and other heparan sulfate proteoglycans of rat glomerulus.Arch Biochem Biophys1989; 269: 576–85.
25.
OikeY., KimataK., ShinomuraT., NakazawaK., SuzukiS.Structural analysis of chick-embryo cartilage proteoglycan by selective degradation with chondroitin lyases (chondroitinases) and endo-beta-D-galactosidase (keratanase).Biochem J1980; 191: 193–207.
26.
YamagataT., SaitoH., HabuchiO., SuzukiS.Purification and properties of bacterial chondroitinases and chondrosulfatases.J Biol Chem1968; 243: 1523–35.
27.
GlosslJ., Schubert-PrinzR., GregoryJ.D., DamleS.P., von FiguraK., KresseH.Receptor-mediated endocytosis of proteoglycans by human fibroblasts involves recognition of the protein core.Biochem J1983; 215: 295–301.
28.
ThomasG.J., ShewringL., McCarthyK.J., CouchmanJ.R., MasonR.M., DaviesM.Rat mesangial cells in vitro synthesize a spectrum of proteoglycan species including those of the basement membrane and interstitium.Kidney Int1995; 48: 1278–89.
29.
HausserH., OberB., Quentin-HoffmannE., SchmidtB., KresseH.Endocytosis of different members of the small chondroitin/dermatan sulfate proteoglycan family.J Biol Chem1992; 267: 11559–64.
30.
HausserH., WedekindP., SperberT., PetersR., HasilikA., KresseH.Isolation and cellular localization of the decorin endocytosis receptor.Eur J Cell Biol1996; 71: 325–31.
31.
Uhlin-HansenL., YanagishitaM.Brefeldin A inhibits the endocytosis of plasma-membrane-associated heparan sulphate proteoglycans of cultured rat ovarian granulosa cells.Biochem J1995; 310: 271–8.
32.
Arroyo-YanguasY., ChengF., IsakssonA., FranssonL.A., MalmstromA., Westergren-ThorssonG.Binding, internalization, and degradation of antiproliferative heparan sulfate by human embryonic lung fibroblasts.J Cell Biochem1997; 64: 595–604.
33.
BaiX., BameK.J., HabuchiH., KimataK., EskoJ.D.Turnover of heparan sulfate depends on 2-O-sulfation of uronic acids.J Biol Chem1997; 272: 23172–9.
34.
YanagishitaM., HascallV.C.Metabolism of proteoglycans in rat ovarian granulosa cell culture. Multiple intracellular degradative pathways and the effect of chloroquine.J Biol Chem1984; 259: 10270–83.
35.
HausserH., WittO., KresseH.Influence of membrane-associated heparan sulfate on the internalization of the small proteoglycan decorin.Exp Cell Res1993; 208: 398–406.
36.
SchaeferL., HausserH., AltenburgerM., UgorcakovaJ., AugustC., FisherL.W.Decorin, biglycan and their endocytosis receptor in rat renal cortex.Kidney Int1998; 54: 1529–41.
37.
HausserH., KresseH.Binding of heparin and of the small proteoglycan decorin to the same endocytosis receptor proteins leads to different metabolic consequences.J Cell Biol1991; 114: 45–52.
38.
ZeillemakerA.M., VerbrughH.A., Hoynck van PapendrechtA.A., LeguitP.CA 125 secretion by peritoneal mesothelial cells.J Clin Pathol1994; 47: 263–5.
39.
ZeillemakerA.M., MulF.P., Hoynck van PapendrechtA.A., KuijpersT.W., RoosD., LeguitP.Polarized secretion of interleukin-8 by human mesothelial cells: A role in neutrophil migration.Immunology1995; 84: 227–32.
40.
LiF.K., DavenportA., RobsonR.L., LoetscherP., RothleinR., WilliamsJ.D.Leukocyte migration across human peritoneal mesothelial cells is dependent on directed chemokine secretion and ICAM-1 expression.Kidney Int1998; 54: 2170–83.
41.
MartinJ., YungS., RobsonR., SteadmanR., DaviesM.Production and regulation of matrix metalloproteinases and their inhibitors by human peritoneal mesothelial cells.Perit Dial Int2000; 20: 524–33.
42.
KolsetS.O., VuongT.T., PrydzK.Apical secretion of chondroitin sulphate in polarized Madin-Darby canine kidney (MDCK) cells.J Cell Sci1999; 112: 1797–801.
43.
DaviesS.J., BryanJ., PhillipsL., RussellG.I.Longitudinal changes in peritoneal kinetics: The effects of peritoneal dialysis and peritonitis.Nephrol Dial Transplant1996; 11: 498–506.
44.
WilliamsJ.D., CraigK.J., TopleyN., Von RuhlandC., FallonM., NewmanG.R.Morphologic changes in the peritoneal membrane of patients with renal disease.J Am Soc Nephrol2002; 13: 470–9.
45.
IozzoR.V., PillarisettiJ., SharmaB., MurdochA.D., DanielsonK.G., UittoJ.Structural and functional characterization of the human perlecan gene promoter. Transcriptional activation by transforming growth factor-beta via a nuclear factor 1-binding element.J Biol Chem1997; 272: 5219–28.
46.
MargettsP.J., GyorffyS., KolbM., YuL., HoffC.M., HolmesC.J.Antiangiogenic and antifibrotic gene therapy in a chronic infusion model of peritoneal dialysis in rats.J Am Soc Nephrol2002; 13: 721–8.
47.
BorderW.A., NobleN.A., YamamotoT., HarperJ.R., YamaguchiY., PierschbacherM.D.Natural inhibitor of transforming growth factor-beta protects against scarring in experimental kidney disease.Nature1992; 360: 361–4.
48.
IsakaY., BreesD.K., IkegayaK., KanedaY., ImaiE., NobleN.A.Gene therapy by skeletal muscle expression of decorin prevents fibrotic disease in rat kidney.Nat Med1996; 2: 418–23.
49.
SchaeferL., MacakovaK., RaslikI., MicegovaM., GroneH.J., SchonherrE.Absence of decorin adversely influences tubulointerstitial fibrosis of the obstructed kidney by enhanced apoptosis and increased inflammatory reaction.Am J Pathol2002; 160: 1181–91.
